Oxygen-Enhanced MRI imaging company BIOXDYN has been shown to have potential in the early diagnosis of cancer

1 December 2015

The technique was pioneered by Prof Geoff Parker at the University of Manchester, patented and then spun-out into Bioxydyn. The company is making great progress supplying imaging services to pharmaceutical companies and developing diagnostic imaging products for use in the clinic. Cancer is just one of a number of areas the company is working on which include Asthma, COPD, Cystic Fibrosis, Rheumatoid Arthritis and others.

More detail can be found at: